EUVIMEDEUVIMED entdecken
Crossref

ADAURA: redefining the role of target therapy in resectable lung adenocarcinoma

Jairo A. Zuluaga, Leonardo Rojas, Oscar Arrieta, Andrés F. Cardona

AME Clinical Trials Review · 2024

DOI: 10.21037/actr-23-17 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AME Clinical Trials Review, 2024. Verfasst von Jairo A. Zuluaga und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zuluaga, J. A., Rojas, L., Arrieta, O., & Cardona, A. F. (2024). ADAURA: redefining the role of target therapy in resectable lung adenocarcinoma. AME Clinical Trials Review. https://doi.org/10.21037/actr-23-17

Vancouver

Zuluaga JA, Rojas L, Arrieta O, Cardona AF. ADAURA: redefining the role of target therapy in resectable lung adenocarcinoma. AME Clinical Trials Review. 2024. doi:10.21037/actr-23-17

BibTeX
@article{Zuluaga2024,
  author = {Zuluaga, Jairo A. and Rojas, Leonardo and Arrieta, Oscar and Cardona, Andrés F.},
  title = {ADAURA: redefining the role of target therapy in resectable lung adenocarcinoma},
  journal = {AME Clinical Trials Review},
  year = {2024},
  doi = {10.21037/actr-23-17}
}
Kostenlos starten →